Stay updated with breaking news from Scientific Operations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
WAYNE, Pa., May 07, 2024 -- Teleflex Incorporated , a global leader in medical technologies, today announced the presentation of new research findings from the 2024 American Urological Association...
The Japan Aerospace Exploration Agency's (JAXA) SLIM moon lander, also known as Moon Sniper, regained power after landing on the lunar surface.
The new CRO facility for proteomics services in Newton, Massachusetts ensures closer proximity to US customers Biognosys’ center of excellence for proteomics innovation at its headquarters near...
A new study published in Nature's cancer journal Oncogene highlights the effectiveness of MDX-124, the first therapeutic drug to target annexin-A1, a protein which is overexpressed in several cancer types and promotes tumour progression.
MDX-124, targeting annexin-A1, shows efficacy in cancer, per Oncogene study in Nature.